| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $123.7B | $123.7B | $121.6B | $121.4B | $116.4B | $27.7B | $28.4B | $27.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $20.7B | $23.3B | $23.3B | $14.0B | $20.8B | $3.9B | $5.2B | $4.5B |
| Net Income | $20.0B | $16.2B | $15.4B | $5.4B | $14.2B | $3.4B | $3.2B | $2.5B |
| EPS (Basic) | $5.41 | $4.17 | $3.73 | $1.22 | $3.09 | $0.74 | $0.69 | $0.55 |
| EPS (Diluted) | $5.39 | $4.14 | $3.71 | $1.21 | $3.04 | $0.73 | $0.68 | $0.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $272.6B | $266.2B | $264.8B | $257.3B | $275.9B | $273.9B | $263.4B | $251.7B |
| Current Assets | $29.6B | $26.8B | $24.0B | $21.8B | $24.8B | $26.7B | $25.4B | $21.8B |
| Cash & Equivalents | $9.5B | $7.3B | $6.2B | $4.7B | $8.7B | $11.7B | $5.5B | $3.8B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $33.5B | $39.6B | $40.2B | $27.9B | $29.3B | $28.8B | $30.3B | $27.6B |
| Stockholders' Equity | $96.9B | $85.6B | $82.7B | $80.9B | $96.1B | $90.3B | $82.7B | $71.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $33.6B | $27.7B | $28.5B | $26.4B | $29.1B | $24.7B | $25.7B | $24.3B |
| Investing Cash Flow | $-16.2B | $-15.7B | $-7.2B | $-14.1B | $-13.4B | $-12.0B | $-14.8B | $-50.9B |
| Capital Expenditures | $11.8B | $12.2B | $12.2B | $10.6B | $9.2B | $9.2B | $10.0B | $9.8B |
| Financing Cash Flow | $-14.3B | $-10.9B | $-19.9B | $-16.2B | $-18.6B | $-6.5B | $-9.2B | $27.1B |